D-1179-2023 Class III Terminated
FDA drug recall D-1179-2023 was initiated by RB Health (US) LLC on Aug 29, 2023 and is designated Class III. Reason for recall: Labeling: Label Error on Declared Strength: The incorrect label on the back of the product packaging. The recall status is terminated (terminated Apr 22, 2025). Affected quantity: 6,072 cases/36,426 individual selling units.
Recall details
- Product Type
- Drugs
- Report Date
- Oct 4, 2023
- Initiation Date
- Aug 29, 2023
- Termination Date
- Apr 22, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 6,072 cases/36,426 individual selling units
Product description
Clearasil Rapid Rescue Deep Treatment Pads (Salicylic Acid 2%), packaged in 90-count plastic jar, further packaged in case of 6 jars per case, Distributed by RB Health (US), Parsippany, NJ 07054, NDC 63824-431-90
Reason for recall
Labeling: Label Error on Declared Strength: The incorrect label on the back of the product packaging.
Distribution pattern
USA nationwide
Code information
Lot # KT220211, Exp 07/2024
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1179-2023
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026